The number of patients taking part in industry-sponsored clinical trials in the UK has fallen, despite improvements elsewhere ...

GLP-1 aftercare needs greater investment, warns Dr Federica Amati, citing weight regain, gaps in muscle function assessment ...

Experts call for clearer care pathways to turn cardiovascular testing, biomarkers, and AI insights into earlier treatment and ...

Sonesitatug vedotin improved overall survival in previously treated CLDN18.2-positive gastroesophageal cancer.

Experts at the Future of Health Europe summit explore how prevention, smarter health data and policy reform can shape a ...

Toby Eyre is a Consultant Haematologist at Oxford University Hospitals NHS Foundation Trust, specialising in the management ...

Chronic spontaneous urticaria lacks validated prognostic tools, but clinical features and biomarkers could inform future ...

Explore October's biggest pharma stories, from Regeneron’s muscle-loss trial to Moderna’s melanoma vaccine and the Nobel Prize for optogenetics.

Heart rate variability was associated with fatigue severity in patients undergoing interventional therapy for hepatocellular carcinoma.

A Phase II/III Ebola vaccine trial has begun in Congo amid nearly 4,800 deaths. Read more about the vaccines and outbreak ...

Multisite mucous membrane pemphigoid: only 45% achieved complete remission, with oral and ocular disease limiting treatment ...

Gut-derived metabolites have been linked to greater disease severity in multiple sclerosis. Learn how metabolomic profiles ...